Alkermes Plc said on Tuesday its long-acting injectable therapy for schizophrenia has helped reduce symptoms and can become an effective option for ensuring patients stay on medication even after being discharged from hospital.
from Reuters: Health News https://reut.rs/2UpW2pu
via
IFTTT
0 comments:
Post a Comment